Monthly Archives: October 2019

SunGen Pharma Receives Eighth ANDA Approval from US FDA

PRINCETON, N.J., Oct. 31, 2019 (GLOBE NEWSWIRE) — SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it has received its eighth ANDA approval from the US Food and Drug Administration (FDA).…

British American Tobacco Selects Synchronoss Digital Experience Platform to Speed Delivery of Highly Optimized Customer Journeys

New pilot project spans three European countries to support in-store sales team members

BRIDGEWATER, N.J., Oct. 31, 2019 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (NASDAQ:SNCR), a global leader and innovator of cloud, messaging, digital and IoT products, today announced that it is launching a multi-country pilot of the Synchronoss Digital Experience Platform (DXP) for British American Tobacco (BAT), a leading, multi-category consumer goods company providing tobacco and nicotine products to millions of adult consumers around the world.…

K2 Expands Footprint in Asia-Pacific Region with Acquisition of Australian Distributor

Low-code application development company to expand presence in Australia to meet increasing demand for cloud-based process automation solutions

BELLEVUE, Wash., Oct. 31, 2019 (GLOBE NEWSWIRE) — SourceCode Technology Holdings, Inc. (“K2”), a leader in enterprise low-code application development, today announced the acquisition of its distributor SourceCode ANZ Pty Ltd.

Bombardier Reports Third Quarter 2019 Results

  • Consolidated revenues of $3.7 billion, representing 8% organic growth(1)
  • Consolidated adjusted EBITDA(2) and adjusted EBIT(2) of $255 million and $159 million, respectively; $143 million of reported EBIT
  • Free cash flow usage(2) of $682 million, supporting Global 7500 and Transportation ramp-up; $557 million operating cash flow usage
  • Clear roadmap to full year revenues, earnings(4) and free cash flow guidance supported by planned fourth quarter delivery schedules at Aviation and Transportation(3)

All amounts in this press release are in U.S.

Bombardier Announces Definitive Agreement to Sell Aerostructures Business to Spirit AeroSystems Holding, Inc.

  • Sale of aerostructures business supports Aviation transformation, refocuses on business aviation and strengthens liquidity
  • Expected cash proceeds of $500 million (1) plus the assumptions of liabilities
  • Transaction implies enterprise value to 2019E EBITDA multiple of approximately 10x  All amounts in this press release are in U.S.

Ingredion Incorporated Reports Third Quarter 2019 Results

  • Third quarter 2019 reported and adjusted EPS* were $1.47 and $1.82, respectively, compared with $1.32 and $1.70 in the third quarter 2018, respectively
  • Year-to-date 2019 reported and adjusted EPS were $4.51 and $5.03, respectively, down from $4.80 of reported EPS and down from $5.31 of adjusted EPS in the year-ago period
  • 2019 adjusted EPS expected to be in the range of $6.45-$6.65

WESTCHESTER, Ill., Oct.…

Sanofi Q3 well on track

Paris, October 31, 2019

Sanofi Q3 well on track

  Q3 2019 Change Change
at CER
9M 2019 Change Change
at CER
IFRS net sales reported €9,499m +1.1% -1.1% €26,518m +4.1% +2.2%
IFRS net income reported €1,766m -22.3% €2,816m -30.5%(2)
IFRS EPS reported €1.49 -18.6% €2.33 -28.3%(2)
Business net income(1) €2,399m +4.3% +0.2% €5,805m +6.4% +4.1%
Business EPS(1) €1.92 +4.3% 0.0% €4.65 +6.4% +4.1%
Third-quarter 2019 sales performance(3) led by Sanofi Genzyme and Emerging Markets
  • Net sales were €9,499 million, up 1.1% on a reported basis, down 1.1%(3) at CER and up 0.5% at CER/CS(4).